Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Réglementation et droit · 18/10/19961 min de lecture
CareLink Corp.; Premarket Approval of CareFoneSUPTM Home Uterine Activity Monitoring System, Model 2001
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is announcing its approval of the application by CareLink Corp., Santa Ana, CA, for premarket approval, under the Federal Food, Drug, and Cosmetic Act (the act), of CareFone TM Home Uterine Activity Monitoring System, Model 2001. FDA's Center for Devices and Radiological Health (CDRH) notified the applicant, by letter of September 29, 1995, of the approval of the application.
Langue originale de la source: Federal Register — All DocumentsOuvrir le communiqué original →